MYX Insider Trading

Insider Ownership Percentage: 24.96%
Insider Buying (Last 12 Months): A$149,055.04
Insider Selling (Last 12 Months): A$0.00

Mayne Pharma Group Insider Trading History Chart

This chart shows the insider buying and selling history at Mayne Pharma Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mayne Pharma Group Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/12/2020 01:00 AM ET

This chart shows the closing price history over time for MYX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Mayne Pharma Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2023Shawn O'BrienInsiderIssued290,554A$5.85A$1,699,740.90
12/1/2023Frank CondellaInsiderBuy7,154A$5.43A$38,810.45
10/25/2023Kathryn MacFarlaneInsiderBuy18,000A$3.84A$69,120.00
10/23/2023Ann CustinInsiderBuy6,037A$3.35A$20,205.84
10/20/2023Ann CustinInsiderBuy6,250A$3.35A$20,918.75
4/17/2023Ann CustinInsiderBuy9,075A$4.06A$36,844.50
4/13/2023Patrick BlakeInsiderBuy3,097A$4.07A$12,592.40
3/29/2023Kathryn MacFarlaneInsiderBuy20,000A$3.81A$76,160.00
3/27/2023Frank CondellaInsiderBuy3,210A$3.52A$11,289.57
3/24/2023Frank CondellaInsiderBuy17,788A$3.52A$62,684.91
9/30/2022Scott RichardsInsiderTransfer5,585,369A$0.28A$1,535,976.48
8/1/2022Scott RichardsInsiderCancelled6,608,851A$0.35A$2,313,097.85
9/1/2021Frank CondellaInsiderBuy412,121A$0.33A$136,824.17
See Full Table

SEC Filings (Institutional Ownership Changes) for Mayne Pharma Group (ASX:MYX)

17.60% of Mayne Pharma Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Mayne Pharma Group logo
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Read More on Mayne Pharma Group

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

5,467,533 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

0.84%

Beta

1.31

Who are the company insiders with the largest holdings of Mayne Pharma Group?

Mayne Pharma Group's top insider investors include:
  1. Ann Custin (Insider)
  2. Frank Condella (Insider)
  3. Kathryn MacFarlane (Insider)
  4. Patrick Blake (Insider)
  5. Scott Richards (Insider)
  6. Shawn O'Brien (Insider)
Learn More about top insider investors at Mayne Pharma Group.